Table 2. Incidence of complete response to antineoplastic chemotherapy-induced nausea and vomiting according to the occurrence phase and emetogenic chemotherapy. Belo Horizonte (MG) Brazil, 2015.
| Emetogenic chemotherapy n = 269 | p* | ||||
|---|---|---|---|---|---|
| HEC (n = 152; 56.5%) | MEC (n = 117; 43.5%) | ||||
| Complete phase (acute/late phase) | |||||
| Complete nausea and vomiting Response | 49 (32.2) | 55 (47.0) | 0.014 | ||
| Complete vomiting response | 87 (57.2) | 94 (80.3) | < 0.001 | ||
| Complete nausea response | 56 (36.8) | 57 (48.7) | 0.050 | ||
| Acute phase | |||||
| Complete nausea and vomiting Response | 97 (64.2) | 86 (73.5) | 0.106 | ||
| Complete vomiting response | 128 (84.8) | 110 (94.0) | 0.017 | ||
| Complete nausea response | 98 (64.9) | 87 (74.4) | 0.097 | ||
| Late phase | |||||
| Complete nausea and vomiting Response | 56 (36.8) | 57 (48.7) | 0.050 | ||
| Complete vomiting response | 93 (61.2) | 97 (82.9) | < 0.001 | ||
| Complete nausea response | 62 (40.8) | 60 (51.3) | 0.087 | ||
HEC: high emetogenic chemotherapy; MEC: moderate emetogenic chemotherapy.
*
Chi-square test.